|Mr. Richard Carreon||MD, CEO, Pres & Exec. Director||716,7k||N/A||N/A|
|Mr. David Michae Adams B.Sc., J.D., BSc||Sr. VP of Operations & Strategic Planning||460,79k||N/A||N/A|
|Mr. Shashi Tripathi||Chief Technology Officer||527,59k||N/A||N/A|
|Mr. Dennis Schlaht||Sr. VP of R&D and Technology||436,16k||N/A||N/A|
|Ms. Catherine Kingsford||Sr. VP of Medical Affairs||349,38k||N/A||N/A|
|Mr. Timothy Cruickshank||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Michael John Bassett||Sr. VP of Corp. & Strategic Devel.||N/A||N/A||N/A|
|Ms. Nancy T. Deisinger||VP of HR||N/A||N/A||N/A|
|Dr. Frank A. Vicini||Chief Medical Officer||N/A||N/A||N/A|
|Ms. Leanne Ralph A.C.I.S., BBus, ACIS, AAICD||Company Sec.||N/A||N/A||N/A|
ImpediMed Limited, a medical software technology company, together with its subsidiaries, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. It offers SOZO, a noninvasive bioimpedance spectroscopy device for the detection of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company sells its devices to hospitals and clinics. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.
ImpediMed Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.